Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials

European Journal of Cancer

Volumn 61, Issue , 2016, Pages 146-156

  Coureau, Gaëlle ^a,b,c   Salmi, L Rachid ^a,b,c   Etard, Cécile ^d   Sancho Garnier, Hélène ^e   Sauvaget, Catherine ^f   Mathoulin Pélissier, Simone ^a,b,g,h  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^e Fondation JBD Prevention Cancer   (France)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^g Centre of Clinical Investigation Clinical Epidemiology   (France)

^h INSTITUT BERGONIÉ   (France)

Author keywords

Low dose computed tomography; Lung cancer; Mass screening; Mortality; Tobacco

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; LUNG CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SMOKING; SMOKING CESSATION PROGRAM; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TOBACCO; ADVERSE EFFECTS; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG NEOPLASMS; MASS SCREENING; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; RISK FACTOR; SURVIVAL ANALYSIS; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84969922391     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.04.006     Document Type: Review

References (58)

1. J. Ferlay, I. Soerjomataram, R. Dikshit, and et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 5 2015 Mar 1 E359 E386
2. C.J. Murray, C. Atkinson, K. Bhalla, and et al. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors JAMA 310 6 2013 Aug 14 591 608
3. N. Creighton, D. Perez, and T. Cotter Smoking-attributable cancer mortality in NSW, Australia, 1972-2008 Public Health Res Pract 25 3 2015 e2531530
4. P. Hanly, I. Soerjomataram, and L. Sharp Measuring the societal burden of cancer: the cost of lost productivity due to premature cancer-related mortality in Europe Int J Cancer 136 4 2015 Feb 15 E136 E145
5. World Health Organization The WHO report on the global tobacco epidemic. Warning about the danger of tobacco 2011 WHO Geneva, Switzerland
6. R. De Angelis, M. Sant, M.P. Coleman, and et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study Lancet Oncol 15 1 2014 Jan 23 34
7. N.N.A. Howlader, M. Krapcho, J. Garshell, D. Miller, and S.F. Altekruse SEER cancer statistics review, 1975-2012 2015 National Cancer Institute Bethesda, MD http://seercancergov/csr/1975-2012/ based on November 2014 SEER data submissionosted to the SEER web site, April 2015
8. G.M. Dores, O. Qubaiah, A. Mody, and et al. A population-based study of incidence and patient survival of small cell carcinoma in the United States, 1992-2010 BMC Cancer 15 2015 185
9. J. Zhang, K.A. Gold, H.Y. Lin, and et al. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry J Thorac Oncol 10 4 2015 Apr 682 690
10. V.W. Chen, B.A. Ruiz, M.C. Hsieh, and et al. Analysis of stage and clinical/prognostic factors for lung cancer from SEER registries: AJCC staging and collaborative stage data collection system Cancer 120 Suppl. 23 2014 Dec 1 3781 3792
11. R. Manser, A. Lethaby, L.B. Irving, and et al. Screening for lung cancer Cochrane Database Syst Rev. 6 2013 CD001991
12. D.R. Aberle, A.M. Adams, C.D. Berg, and et al. Reduced lung-cancer mortality with low-dose computed tomographic screening N Engl J Med 365 5 2011 Aug 4 395 409
13. N.M. Kanodra, G.A. Silvestri, and N.T. Tanner Screening and early detection efforts in lung cancer Cancer 121 9 2015 May 1 1347 1356
14. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Lung cancer screening. [Internet] 2015 [cited 28 2015 oct 12]. Available from: http://www.nccn.org
15. D. Moher, A. Liberati, J. Tetzlaff, and et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
16. K.F. Schulz, D.G. Altman, and D. Moher CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials J Clin Epidemiol 63 8 2010 Aug 834 840
17. M. Zwarenstein, S. Treweek, J.J. Gagnier, and et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement BMJ 337 2008 a2390
18. T. Blanchon, J.M. Brechot, P.A. Grenier, and et al. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR) Lung Cancer 58 1 2007 Oct 50 58
19. J.K. Gohagan, P.M. Marcus, R.M. Fagerstrom, and et al. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer Lung Cancer 47 1 2005 Jan 9 15
20. D.R. Aberle, C.D. Berg, W.C. Black, and et al. The National Lung Screening Trial: overview and study design Radiology 258 1 2011 Jan 243 253
21. M. Infante, F.R. Lutman, S. Cavuto, and et al. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial Lung Cancer 59 3 2008 Mar 355 363
22. J.H. Pedersen, H. Ashraf, A. Dirksen, and et al. The Danish randomized lung cancer CT screening trial - overall design and results of the prevalence round J Thorac Oncol 4 5 2009 May 608 614
23. C.A. van Iersel, H.J. de Koning, G. Draisma, and et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON) Int J Cancer 120 4 2007 Feb 15 868 874
24. A. Lopes Pegna, G. Picozzi, M. Mascalchi, and et al. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT Lung Cancer 64 1 2009 Apr 34 40
25. U. Pastorino, M. Rossi, V. Rosato, and et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial Eur J Cancer Prev 21 3 2012 May 308 315
26. N. Becker, E. Motsch, M.L. Gross, and et al. Randomized study on early detection of lung cancer with MSCT in Germany: study design and results of the first screening round J Cancer Res Clin Oncol 138 9 2012 Sep 1475 1486
27. D.R. Baldwin, S.W. Duffy, N.J. Wald, and et al. UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer Thorax 66 4 2011 Apr 308 313
28. F.J. Larke, R.L. Kruger, C.H. Cagnon, and et al. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial AJR Am J Roentgenol 197 5 2011 Nov 1165 1169
29. M. Mascalchi, L.N. Mazzoni, M. Falchini, and et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT Br J Radiol 85 1016 2012 Aug 1134 1139
30. D.R. Aberle, A.M. Adams, C.D. Berg, and et al. Baseline characteristics of participants in the randomized national lung screening trial J Natl Cancer Inst 102 23 2010 Dec 1 1771 1779
31. M.S. Hestbech, V. Siersma, A. Dirksen, and et al. Participation bias in a randomised trial of screening for lung cancer Lung Cancer 73 3 2011 Sep 325 331
32. P.F. Pinsky, T.R. Church, G. Izmirlian, and et al. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology Cancer 119 22 2013 Nov 15 3976 3983
33. Z. Saghir, A. Dirksen, H. Ashraf, and et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT Thorax 67 4 2012 Apr 296 301
34. M.M. Wille, A. Dirksen, H. Ashraf, and et al. Results of the Randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling Am J Respir Crit Care Med 193 5 2016 Mar 1 542 551
35. N. Becker, E. Motsch, M.L. Gross, and et al. Randomized study on early detection of lung cancer with MSCT in Germany: results of the first 3 years of follow-up after randomization J Thorac Oncol 10 6 2015 Jun 890 896
36. K.A. van den Bergh, M.L. Essink-Bot, G.J. Borsboom, and et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial Eur Respir J 38 1 2011 Jul 154 161
37. I.F. Gareen, F. Duan, E.M. Greco, and et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial Cancer 2014 Jul 25
38. J.F. Rasmussen, V. Siersma, J.H. Pedersen, and et al. Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST) Lung Cancer 87 1 2015 Jan 65 72
39. M. Infante, S. Cavuto, F.R. Lutman, and et al. Long-term follow-up results of the DANTE Trial, a randomized study of lung cancer screening with spiral computed tomography Am J Respir Crit Care Med 2015 Mar 11
40. E.F. Patz Jr., P. Pinsky, C. Gatsonis, and et al. Overdiagnosis in low-dose computed tomography screening for lung cancer JAMA Intern Med 174 2 2014 Feb 1 269 274
41. J.L. Carter, R.J. Coletti, and R.P. Harris Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods BMJ 350 2015 g7773
42. S.M. Carter, W. Rogers, I. Heath, and et al. The challenge of overdiagnosis begins with its definition BMJ 350 2015 h869
43. W.C. Black, I.F. Gareen, S.S. Soneji, and et al. Cost-effectiveness of CT screening in the National Lung Screening Trial N Engl J Med 371 19 2014 Nov 6 1793 1802
44. J.F. Rasmussen, V. Siersma, J.H. Pedersen, and et al. Healthcare costs in the Danish randomised controlled lung cancer CT-screening trial: a registry study Lung Cancer 83 3 2014 Mar 347 355
45. P.B. Bach, J.N. Mirkin, T.K. Oliver, and et al. Benefits and harms of CT screening for lung cancer: a systematic review JAMA 307 22 2012 Jun 13 2418 2429
46. J.K. Field, R. van Klaveren, J.H. Pedersen, and et al. European randomized lung cancer screening trials: post NLST J Surg Oncol 108 5 2013 Oct 280 286
47. M. Gopal, S.E. Abdullah, J.J. Grady, and et al. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials J Thorac Oncol 5 8 2010 Aug 1233 1239
48. L.L. Humphrey, M. Deffebach, M. Pappas, and et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation Ann Intern Med 159 6 2013 Sep 17 411 420
49. A. Vachani, and J.R. Jett Screening for lung cancer. Improving outcomes with better patient selection Am J Respir Crit Care Med 193 5 2016 Mar 1 478 479
50. C. Duda, I. Mahon, M.H. Chen, and et al. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial Clin Trials 8 2 2011 Apr 214 223
51. L.B. Hinshaw, S.A. Jackson, and M.Y. Chen Direct mailing was a successful recruitment strategy for a lung-cancer screening trial J Clin Epidemiol 60 8 2007 Aug 853 857
52. P.M. Marcus, S. Lenz, D. Sammons, and et al. Recruitment methods employed in the National Lung Screening Trial J Med Screen 19 2 2012 Jun 94 102
53. J.K. Field, A. Devaraj, S.W. Duffy, and et al. CT screening for lung cancer: is the evidence strong enough? Lung Cancer 91 2016 Jan 29 35
54. M.C. Tammemagi, and S. Lam Screening for lung cancer using low dose computed tomography BMJ 348 2014 g2253
55. V. Prasad, J. Lenzer, and D.H. Newman Why cancer screening has never been shown to "save lives"-and what we can do about it BMJ 352 2016 h6080
56. C.I. Henschke, P. Boffetta, O. Gorlova, and et al. Assessment of lung-cancer mortality reduction from CT Screening Lung Cancer 71 3 2011 Mar 328 332
57. C. Begg, M. Cho, S. Eastwood, and et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement JAMA 276 8 1996 Aug 28 637 639
58. L. Salmi, G. Coureau, M. Bailhache, and et al. To screen or not to screen: reconciling individual and population perspectives on screening 2016 Submitted, in revision